Most Recent
A fight has broken out between the litigation funder and the lawyers representing 15,000 seaweed farmers in a class action against oil exploration company PTTEP Australia over a spill at its Montara oil field in the Timor Sea.
Wilsons Advisory and Stockbroking has dodged a claim by rival Elston Private Wealth over a veteran employee who jumped ship with confidential information.
Defunct stockbroker Halifax Investment Services has sued law firm King & Wood Mallesons and its former auditor Bentleys for allegedly failing to advise that it had to hold client funds used to trade on its online platforms on trust.
Three insurers for builder Icon are planning to test the reasonableness of a structural engineer's defence costs in a now settled class action brought by apartment owners in Sydney's ill-fated Opal Tower.
The protective scope of whistleblower laws will be tested in a $13 million suit brought by a former Greenwoods & Herbert Smith Freehills partner allegedly sacked for complaining about the tax avoidance strategy of construction giant Lendlease, the advisory firm's biggest client.
The maker of Finish dishwashing products has had two of its trade marks struck from the register after losing an intellectual property suit against an emerging rival.
Clive Palmer’s Queensland Nickel refinery has lost its appeal of a decision ordering it pay $26.6 million for natural gas charges owed after a court rejected claims it did not need to repay the money because pipeline owners had breached their duties.
London firm Mishcon de Reya faces a lawsuit alleging the firm knowingly assisted a founding partner of Lipman Karas to breach his duties when it reached an agreement to open a Hong Kong office.
A judge has questioned how the government can enforce a “restrictive” undertaking with a former member of the Australian Defence Force who will give key evidence in a class action alleging the Commonwealth contaminated Indigenous land with toxic firefighting foam.
Pharmaceutical ingredient producer Alkaloids of Australia is facing a maximum $30 million penalty but has argued it should pay less than $1 million after pleading guilty to cartel conduct over the supply of a key chemical found in generic stomach cramp drugs.